Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Introduction to Nuclear Reprogramming

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy.

International journal of molecular sciences·2026

Same author

RNA Therapeutics: Bridging Discovery and Clinical Implementation.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Molecular Mechanisms of Innate Immune Sensing of Exogenous RNAs.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Effects of Nucleoside Modifications on mRNA Translation: Choosing the Right Modifications.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Assessing the Immunogenicity of Synthetic RNA Using Blood Cells.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Production of mRNA-Loaded Dendritic Cell Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025

Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 8, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

Large-Scale Production of Unmodified mRNA for Reprogramming Human Dendritic Cells and T Cells.

Stein Sæbøe-Larssen¹, Mouldy Sioud²

¹Section for Cellular Therapy, Department of Oncology, Oslo University Hospital Radiumhospitalet, Oslo, Norway.

Methods in Molecular Biology (Clifton, N.J.)

|August 28, 2025

Summary

This summary is machine-generated.

In vitro transcribed messenger RNA (mRNA) is a versatile tool for creating vaccines and engineered cells. This method enables rapid development of therapies like dendritic cell vaccines and chimeric antigen receptor T cells.

Keywords:

Dendritic cells In vitro transcription Nanoparticles T7 RNA polymerase mRNA vaccines

More Related Videos

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

Related Experiment Videos

Last Updated: Apr 8, 2026

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Published on: November 26, 2018

Area of Science:

Biotechnology
Molecular Medicine
Vaccinology

Background:

Messenger RNA (mRNA) technology offers a powerful platform for protein expression in biotechnology and medicine.
In vitro transcribed (IVT) mRNA is produced using a DNA template and T7 RNA polymerase.
IVT mRNA has demonstrated significant potential, notably in the development of highly effective COVID-19 vaccines.

Purpose of the Study:

To detail the production and purification process of unmodified IVT mRNA.
To outline the application of IVT mRNA for ex vivo generation of dendritic cell (DC) mRNA vaccines.
To describe the use of IVT mRNA for engineering T cells with chimeric antigen receptors (CARs).

Main Methods:

Utilizing a DNA template encoding the protein of interest for in vitro transcription.
Employing T7 RNA polymerase, ribonucleoside triphosphates, and essential cofactors for mRNA synthesis.
Implementing purification techniques for the produced mRNA, suitable for ex vivo or in vivo applications.

Main Results:

Successful production and purification of unmodified IVT mRNA were achieved.
The described methods enable the generation of mRNA-loaded dendritic cells for vaccination.
The protocol facilitates the engineering of T cells with chimeric antigen receptors using IVT mRNA.

Conclusions:

IVT mRNA production is a robust and adaptable method for biotechnological and medical applications.
This technology provides a versatile platform for developing advanced cell-based therapies and vaccines.
The described procedures are crucial for the ex vivo generation of DC mRNA vaccines and CAR T cells.